Factors | Univariate PFS | Multivariate PFS | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age > 65, yes | 0.51 (0.31–0.87) | 0.013 | 0.52 (0.31–0.88) | 0.014 |
Male, yes | 1.10 (0.72–1.69) | 0.66 | 1.02 (0.65–1.56) | 0.95 |
Favorable prognosis, yes | 1.43 (0.95–2.14) | 0.084 | 1.41 (0.93–2.1) | 0.099 |
Karnofsky performance status ≥90, n (%) | 1.18 (0.79–1.76) | 0.43 | – | – |
≥ 2 metastatic sites, n (%) | 1.35 (0.90–2.01) | 0.15 | – | – |
Hemoglobin, g/dL | 0.98 (0.87–1.10) | 0.69 | – | – |
Leucocytes, 109/L | 1.03 (0.92–1.15) | 0.59 | – | – |
Neutrophils, 109/L | 1.03 (0.91–1.17) | 0.65 | – | – |
Platelets, 109/L | 1.00 (1.00–1.005) | 0.044 | – | – |
Total calcium, mg/dL | 1.074 (0.83–1.38) | 0.58 | – | – |
LDH, mg/dL | 0.99 (0.99–1.00) | 0.28 | – | – |